Feed NVZMY
NV

Novozymes A/S NVZMY OTC · Basic materials · Denmark

$66.06 -0.22% -$0.15

Market cap
28.1B €
Enterprise value
30.8B €
P/E
-
Forward P/E
4.0x
PEG
0.0x
P/S
6.4x
P/FCF
40.2x
EV/EBITDA
20.7x
ROIC
5.0%
Gross margin
56.3%
Net margin
-4.6%
Dividend yield
1.07%
Payout ratio
-
Net debt/EBITDA
1.5x
Beta
0.62
Free float
74.6%

About the company

Novozymes A/S is a Danish biotechnology company founded in 2000 and headquartered in Bagsværd, Denmark. The company is a leader in the development and production of industrial enzymes and microorganisms, which are used in a wide range of industries, including food, agriculture, textiles, biofuels, and wastewater treatment. Novozymes focuses on sustainability and innovation, with its products helping to increase manufacturing efficiency, reduce environmental impact, and support the transition to a more sustainable economy. The company operates globally, with its products distributed to over 130 countries.

Sector

Basic Materials

Industry

Chemicals - Specialty

CEO

Ester Baiget

Employees

11,641

Headquarters

Lyngby

Valuation

Is today's price reasonable?

  • What to watch: The share price is above the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Analysts expect revenue to grow by 712% this fiscal year.
  • What to watch: Revenue fell by 38% a year over the last 3 years.
  • What to watch: It missed profit estimates 8 times in the last 8 quarters.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 EUR of revenue, 16 EUR is left as free cash.
  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy